NewEdge Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
|
|||||
|
2025
Q1 | $844K | Buy |
|
|||||
|
2024
Q4 | $667K | Sell |
|
|||||
|
2024
Q3 | $582K | Buy |
|
|||||
|
2024
Q2 | $426K | Buy |
|
|||||
|
2024
Q1 | $397K | Buy |
|
|||||
|
2023
Q4 | $59.6K | Buy |
|
|||||
|
2023
Q3 | $5.4K | Hold |
|
|||||
|
2023
Q2 | $4.53K | Sell |
|
|||||
|
2023
Q1 | $46.7K | Sell |
|
|||||
|
2022
Q4 | $1.61M | Buy |
|